Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 May 11. pii: 10.1212/WNL.0000000000005660. doi: 10.1212/WNL.0000000000005660. [Epub ahead of print]

PMID:
29752303
2.

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.

Strydom A, Heslegrave A, Startin CM, Mok KY, Hardy J, Groet J, Nizetic D, Zetterberg H; LonDownS Consortium.

Alzheimers Res Ther. 2018 Apr 10;10(1):39. doi: 10.1186/s13195-018-0367-x.

3.

Rhinovirus respiratory tract infection in hospitalized adult patients is associated with TH2 response irrespective of asthma.

To KKW, Lu L, Fong CHY, Wu AKL, Mok KY, Yip CCY, Ke YH, Sze KH, Lau SKP, Hung IFN, Yuen KY.

J Infect. 2018 May;76(5):465-474. doi: 10.1016/j.jinf.2018.02.005. Epub 2018 Feb 15.

PMID:
29454786
4.

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis.

Zhou X, Chen Y, Mok KY, Zhao Q, Chen K, Chen Y, Hardy J, Li Y, Fu AKY, Guo Q, Ip NY; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1697-1706. doi: 10.1073/pnas.1715554115. Epub 2018 Feb 5.

5.

Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yaldizli Ö, Sethi V, Pardini M, Tur C, Mok KY, Muhlert N, Liu Z, Samson RS, Wheeler-Kingshott CAM, Yousry TA, Houlden H, Hardy J, Miller DH, Chard DT.

Mult Scler Relat Disord. 2018 Jan;19:168-170. doi: 10.1016/j.msard.2016.08.006. Epub 2016 Aug 12. No abstract available.

PMID:
29409599
6.

NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.

Blauwendraat C, Faghri F, Pihlstrom L, Geiger JT, Elbaz A, Lesage S, Corvol JC, May P, Nicolas A, Abramzon Y, Murphy NA, Gibbs JR, Ryten M, Ferrari R, Bras J, Guerreiro R, Williams J, Sims R, Lubbe S, Hernandez DG, Mok KY, Robak L, Campbell RH, Rogaeva E, Traynor BJ, Chia R, Chung SJ; International Parkinson's Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium, Hardy JA, Brice A, Wood NW, Houlden H, Shulman JM, Morris HR, Gasser T, Krüger R, Heutink P, Sharma M, Simón-Sánchez J, Nalls MA, Singleton AB, Scholz SW.

Neurobiol Aging. 2017 Sep;57:247.e9-247.e13. doi: 10.1016/j.neurobiolaging.2017.05.009. Epub 2017 May 17.

PMID:
28602509
7.

Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population.

Giri A, Mok KY, Jansen I, Sharma M, Tesson C, Mangone G, Lesage S, Bras JM, Shulman JM, Sheerin UM; International Parkinson's Disease Consortium (IPDGC), Díez-Fairen M, Pastor P, Martí MJ, Ezquerra M, Tolosa E, Correia-Guedes L, Ferreira J, Amin N, van Duijn CM, van Rooij J, Uitterlinden AG, Kraaij R, Nalls M, Simón-Sánchez J.

Neurobiol Aging. 2017 Feb;50:167.e11-167.e13. doi: 10.1016/j.neurobiolaging.2016.10.004. Epub 2016 Oct 11.

8.

Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.

Lubbe SJ, Escott-Price V, Gibbs JR, Nalls MA, Bras J, Price TR, Nicolas A, Jansen IE, Mok KY, Pittman AM, Tomkins JE, Lewis PA, Noyce AJ, Lesage S, Sharma M, Schiff ER, Levine AP, Brice A, Gasser T, Hardy J, Heutink P, Wood NW, Singleton AB, Williams NM, Morris HR; for International Parkinson’s Disease Genomics Consortium.

Hum Mol Genet. 2016 Dec 15;25(24):5483-5489. doi: 10.1093/hmg/ddw348.

9.

Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology.

Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T.

Brain. 2016 Dec;139(Pt 12):3237-3252. Epub 2016 Oct 25.

PMID:
27797812
10.

Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.

To KK, Mok KY, Chan AS, Cheung NN, Wang P, Lui YM, Chan JF, Chen H, Chan KH, Kao RY, Yuen KY.

J Gen Virol. 2016 Aug;97(8):1807-17. doi: 10.1099/jgv.0.000512. Epub 2016 Jun 2.

PMID:
27259985
11.

HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yaldizli Ö, Sethi V, Pardini M, Tur C, Mok KY, Muhlert N, Liu Z, Samson RS, Wheeler-Kingshott CA, Yousry TA, Houlden H, Hardy J, Miller DH, Chard DT.

Mult Scler Relat Disord. 2016 May;7:47-52. doi: 10.1016/j.msard.2016.03.003. Epub 2016 Mar 7.

PMID:
27237756
12.

Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.

Mok KY, Sheerin U, Simón-Sánchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM, Noyce AJ, Mencacci NE, Lubbe SJ; International Parkinson's Disease Genomics Consortium (IPDGC), Williams-Gray CH, Barker RA, van Dijk KD, Berendse HW, Heutink P, Corvol JC, Cormier F, Lesage S, Brice A, Brockmann K, Schulte C, Gasser T, Foltynie T, Limousin P, Morrison KE, Clarke CE, Sawcer S, Warner TT, Lees AJ, Morris HR, Nalls MA, Singleton AB, Hardy J, Abramov AY, Plagnol V, Williams NM, Wood NW.

Lancet Neurol. 2016 May;15(6):585-96. doi: 10.1016/S1474-4422(16)00071-5. Epub 2016 Mar 24.

13.

Pulmonary and extrapulmonary complications of human rhinovirus infection in critically ill patients.

To KK, Lau SK, Chan KH, Mok KY, Luk HK, Yip CC, Ma YK, Sinn LH, Lam SH, Ngai CW, Hung IF, Chan KH, Yuen KY.

J Clin Virol. 2016 Apr;77:85-91. doi: 10.1016/j.jcv.2016.02.014. Epub 2016 Feb 20.

PMID:
26921740
14.

Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?

Ling H, Kearney S, Yip HL, Silveira-Moriyama L, Revesz T, Holton JL, Strand C, Davey K, Mok KY, Polke JM, Lees AJ.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):633-41. doi: 10.1136/jnnp-2015-310756. Epub 2015 Jul 24.

PMID:
26209716
15.

Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35 (2014) 1513.e1-1513.e5].

Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J.

Neurobiol Aging. 2014 Dec;35(12):2886. doi: 10.1016/j.neurobiolaging.2014.08.026. Epub 2014 Sep 6. No abstract available.

16.

Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35 (2014) 1513.e1-1513.e5].

Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J.

Neurobiol Aging. 2014 Nov;35(11):2659. doi: 10.1016/j.neurobiolaging.2014.06.017. Epub 2014 Jul 17. No abstract available.

17.

Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Bras J, Hersheson J, Stamelou M, Pittman AM, Noyce AJ, Mok KY, Opladen T, Kunstmann E, Hodecker S, Münchau A, Volkmann J, Samnick S, Sidle K, Nanji T, Sweeney MG, Houlden H, Batla A, Zecchinelli AL, Pezzoli G, Marotta G, Lees A, Alegria P, Krack P, Cormier-Dequaire F, Lesage S, Brice A, Heutink P, Gasser T, Lubbe SJ, Morris HR, Taba P, Koks S, Majounie E, Raphael Gibbs J, Singleton A, Hardy J, Klebe S, Bhatia KP, Wood NW; International Parkinson’s Disease Genomics Consortium and UCL-exomes consortium.

Brain. 2014 Sep;137(Pt 9):2480-92. doi: 10.1093/brain/awu179. Epub 2014 Jul 2.

18.

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.

Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J.

Neurobiol Aging. 2014 Jun;35(6):1513.e1-5. doi: 10.1016/j.neurobiolaging.2013.12.022. Epub 2013 Dec 27. Erratum in: Neurobiol Aging. 2014 Nov;35(11):2659. Neurobiol Aging. 2014 Dec;35(12):2886.

19.

Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel.

Mok KY, Schneider SA, Trabzuni D, Stamelou M, Edwards M, Kasperaviciute D, Pickering-Brown S, Silverdale M, Hardy J, Bhatia KP.

Mov Disord. 2014 Feb;29(2):245-51. doi: 10.1002/mds.25732. Epub 2013 Nov 13.

20.

Mycobacterium abscessus bacteremia after receipt of intravenous infusate of cytokine-induced killer cell therapy for body beautification and health boosting.

Liu R, To KK, Teng JL, Choi GK, Mok KY, Law KI, Tso EY, Fung KS, Wu TC, Wu AK, Fung SH, Wong SC, Trendell-Smith NJ, Yuen KY.

Clin Infect Dis. 2013 Oct;57(7):981-91. doi: 10.1093/cid/cit443. Epub 2013 Jul 3.

PMID:
23825355
21.

Use of nasopharyngeal aspirate for diagnosis of pneumocystis pneumonia.

To KK, Wong SC, Xu T, Poon RW, Mok KY, Chan JF, Cheng VC, Chan KH, Hung IF, Yuen KY.

J Clin Microbiol. 2013 May;51(5):1570-4. doi: 10.1128/JCM.03264-12. Epub 2013 Feb 13.

22.

A robust model for read count data in exome sequencing experiments and implications for copy number variant calling.

Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, Wood NW, Hambleton S, Burns SO, Thrasher AJ, Kumararatne D, Doffinger R, Nejentsev S.

Bioinformatics. 2012 Nov 1;28(21):2747-54. doi: 10.1093/bioinformatics/bts526. Epub 2012 Aug 31.

23.

High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients.

Mok KY, Koutsis G, Schottlaender LV, Polke J, Panas M, Houlden H.

Neurobiol Aging. 2012 Aug;33(8):1851.e1-5. doi: 10.1016/j.neurobiolaging.2012.02.021. Epub 2012 Mar 22.

24.

Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystonia.

Paisán-Ruiz C, Ruiz-Martinez J, Ruibal M, Mok KY, Indakoetxea B, Gorostidi A, Martí Massó JF.

Mov Disord. 2009 Dec 15;24(16):2428-9. doi: 10.1002/mds.22849. No abstract available.

PMID:
19908320
25.

Use of inert C&D materials for seawall foundation: quality control measures.

Yeung AT, Tham LG, Lee PK, Mok KY, Pei G.

Waste Manag. 2007;27(6):768-77. Epub 2006 Jun 5.

PMID:
16750907
26.

An epidemiological study of motor neuron disease in Hong Kong.

Fong GC, Cheng TS, Lam K, Cheng WK, Mok KY, Cheung CM, Chim CS, Mak W, Chan KH, Tsang KL, Kwan MC, Tsoi TH, Cheung RT, Ho SL.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Sep;6(3):164-8.

PMID:
16247937
27.

Growth hormone regulation of glomerular AT1 angiotensin receptors in adult uninephrectomized male rats.

Mok KY, Sandberg K, Sweeny JM, Zheng W, Lee S, Mulroney SE.

Am J Physiol Renal Physiol. 2003 Dec;285(6):F1085-91. Epub 2003 Jun 24.

28.

Cerebral venous thrombosis in Hong Kong.

Mak W, Mok KY, Tsoi TH, Cheung RT, Ho SL, Chang CM.

Cerebrovasc Dis. 2001;11(3):282-3. No abstract available.

PMID:
11306780
29.

BioJAKE: a tool for the creation, visualization and manipulation of metabolic pathways.

Salamonsen W, Mok KY, Kolatkar P, Subbiah S.

Pac Symp Biocomput. 1999:392-400.

30.

Monomicrobial nonneutrocytic bacterascites due to Burkholderia pickettii.

Yuen KH, Ng FH, Mok KY, Ng WF.

Am J Gastroenterol. 1998 Nov;93(11):2308-9. No abstract available.

PMID:
9820433
31.

A multimodal neurophysiological assessment in terminal renal failure.

Yu YL, Cheng IK, Chang CM, Bruce IC, Mok KY, Zhong WY, Chan YW.

Acta Neurol Scand. 1991 Feb;83(2):89-95.

PMID:
2017903
32.

Cervical spondylotic radiculopathy precipitated by decompression sickness.

Yu YL, Chang CM, Lam TH, Ho KM, Mok KY.

Br J Ind Med. 1990 Nov;47(11):785-7. No abstract available.

33.

Nocardia peritonitis complicating continuous ambulatory peritoneal dialysis.

Chan DT, Cheng IK, Chan PC, Mok KY.

Perit Dial Int. 1990;10(1):99. No abstract available.

PMID:
2085594

Supplemental Content

Support Center